Definitive Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Definitive Healthcare (DH).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

2Buy

5Hold

3Sell

Consensus RatingHold# Analysts10Avg. Consensus PT$4Upside to Avg. PT+262.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 11, 2026	Morgan Stanley	Craig Hettenbach	PT Cut	Equal-Weight	$3→$2
Jun 29, 2026	B of A Securities	Allen Lutz	Downgrade	Buy→Underperform	$4→$1
Mar 30, 2026	Barclays	Saket Kalia	PT Cut	Underweight	$3→$1
Feb 27, 2026	Canaccord Genuity	David Hynes	PT Cut	Hold	$4→$3
Feb 27, 2026	Stephens & Co.	Jeff Garro	PT Cut	Equal-Weight	$3→$2
Dec 9, 2025	Barclays	Saket Kalia	PT Cut	Underweight	$3→$3
Nov 10, 2025	Canaccord Genuity	David Hynes	PT Cut	Hold	$5→$4
Aug 8, 2025	Stifel	David Grossman	PT Raise	Buy	$5→$6
May 12, 2025	Goldman Sachs	Kash Rangan	PT Raise	Neutral	$3→$3
Mar 4, 2025	Goldman Sachs	Kash Rangan	PT Cut	Neutral	$5→$3
Mar 3, 2025	Barclays	Saket Kalia	PT Cut	Underweight	$4→$3
Jan 16, 2025	Needham	Ryan MacDonald	Maintained	Hold	—
Jan 13, 2025	Barclays	Saket Kalia	Downgrade	Equal-Weight→Underweight	$4
Dec 20, 2024	Stephens & Co.	Jeff Garro	Initiate	Equal-Weight	$5
Nov 8, 2024	Needham	Ryan MacDonald	Maintained	Hold	—
Sep 17, 2024	BTIG	David Larsen	Initiate	Buy	$7
Aug 9, 2024	Deutsche Bank	George Hill	PT Cut	Hold	$7→$5
Aug 7, 2024	Barclays	Saket Kalia	PT Cut	Equal-Weight	$6→$4
Aug 7, 2024	Baird	Vikram Kesavabhotla	PT Cut	Neutral	$6→$5
Aug 6, 2024	Morgan Stanley	Craig Hettenbach	PT Cut	Equal-Weight	$9→$5

Analyst Ratings News

PRO
Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $2.5 to $1.5.

Benzinga Newsdesk

PRO
B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Underperform and lowers the price target from $3.5 to $0.7.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $2.75 to $1.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3

Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target from $4 to $3.

Benzinga Newsdesk

PRO
Stephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2

Stephens & Co. analyst Jeff Garro maintains Definitive Healthcare (NASDAQ:DH) with a Equal-Weight and lowers the price target from $3 to $2.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $3 to $2.75.

Benzinga Newsdesk

Definitive Healthcare Corp

Definitive Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

PRO
B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

PRO
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3

PRO
Stephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75

People Also Watch

People Also Watch

Definitive Healthcare Corp

Definitive Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMorgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

PROB of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

PROBarclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

PROCanaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3

PROStephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2

PROBarclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75

People Also Watch

People Also Watch

PRO
Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

PRO
B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

PRO
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3

PRO
Stephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2

PRO
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75